Page last updated: 2024-09-05

orantinib and hesperadin

orantinib has been researched along with hesperadin in 1 studies

Compound Research Comparison

Studies
(orantinib)
Trials
(orantinib)
Recent Studies (post-2010)
(orantinib)
Studies
(hesperadin)
Trials
(hesperadin)
Recent Studies (post-2010) (hesperadin)
110193658033

Protein Interaction Comparison

ProteinTaxonomyorantinib (IC50)hesperadin (IC50)
Aurora kinase AHomo sapiens (human)0.011
Glucose transporterLeishmania mexicana1.114
Serine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)0.78
Hexose transporter 1 Plasmodium falciparum (malaria parasite P. falciparum)1.344
Solute carrier family 2, facilitated glucose transporter member 1Homo sapiens (human)1.434
Maternal embryonic leucine zipper kinaseHomo sapiens (human)0.225
Aurora kinase B-AXenopus laevis (African clawed frog)0.003
Aurora kinase BHomo sapiens (human)0.2006

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bhatt, HG; Borisa, AC1

Reviews

1 review(s) available for orantinib and hesperadin

ArticleYear
A comprehensive review on Aurora kinase: Small molecule inhibitors and clinical trial studies.
    European journal of medicinal chemistry, 2017, Nov-10, Volume: 140

    Topics: Animals; Antineoplastic Agents; Aurora Kinases; Cell Proliferation; Clinical Trials as Topic; Humans; Molecular Structure; Protein Kinase Inhibitors; Small Molecule Libraries

2017